SUPRIYA LIFESCIENCE
Back to Cashflow Statement
|
SUPRIYA LIFESCIENCE Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹165 Cr | ₹113 Cr | ₹64 Cr | ₹49 Cr | ₹76 Cr |
What is the latest Cash Flow from Operating Activities ratio of SUPRIYA LIFESCIENCE ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹165 Cr |
| Mar2024 | ₹113 Cr |
| Mar2023 | ₹64 Cr |
| Mar2022 | ₹49 Cr |
| Mar2021 | ₹76 Cr |
How is Cash Flow from Operating Activities of SUPRIYA LIFESCIENCE Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹165 Cr | 45.34 | |
| Mar2024 | ₹113 Cr | 78.14 | |
| Mar2023 | ₹64 Cr | 30.34 | |
| Mar2022 | ₹49 Cr | -35.69 | |
| Mar2021 | ₹76 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹6,311.2 Cr | -7.8% | -5.4% | 20.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,675.0 Cr | -3% | -2.6% | 21.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,516.0 Cr | -0.5% | 17% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹186,190.0 Cr | 0.6% | 2.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹115,523.0 Cr | -2.2% | 0.8% | -2.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,493.4 Cr | -1.1% | -1.6% | -0.8% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | -7.8% |
-5.4% |
20.8% |
| SENSEX | -1% |
0.7% |
-3.6% |
You may also like the below Video Courses